<DOC>
	<DOCNO>NCT01074424</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor identify learn biomarkers related cancer . It may also help doctor predict well patient respond treatment . PURPOSE : This research study look biomarkers blood sample patient invasive cervical cancer .</brief_summary>
	<brief_title>Studying Biomarkers Blood Samples From Patients With Invasive Cervical Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To develop serum proteomic profile cervical cancer use bank pre-treatment serum specimens patient invasive cervical cancer determine serum proteomic profile possible utility cervical cancer prognosis . Secondary - To develop serum proteomic profile cervical cancer use bank post-treatment serum specimens patient determine serum proteomic profile possible utility cervical cancer prognosis . OUTLINE : This multicenter study . Banked serum specimen use generate proteomic profile .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive adenocarcinoma , squamous cell carcinoma , adenosquamous cell carcinoma cervix Stage IIB , III , IVA disease Eligible evaluable GOG0191 Pre and/or posttreatment serum specimens available proteomic analysis PATIENT CHARACTERISTICS : Patient give consent allow specimen ( ) use future cancer research PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>cervical adenosquamous cell carcinoma</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
</DOC>